trevi therapeutics news：Trevi Therapeutics Announces Appointment of James V. ...
Trevi Therapeutics Announces Appointment of James V. ...
2024年9月30日—TreviTherapeuticsAnnouncesAppointmentofJamesV.Cassella,Ph.D.,asChiefDevelopmentOfficer·Sharethisarticle·WANTYOURCOMPANY'SNEWS ...。其他文章還包含有：「InvestorSite」、「TreviTherapeutics」、「TreviTherapeutics,Inc.(TRVI)StockPrice」、「TreviTherapeuticsReportsSecondQuarter2024Financial...」、「TreviTherapeutics」、「TRVI:TreviTherapeuticsInc」、「TreviTherapeutics」、「TreviThera...
查看更多 離開網站
Investor Site
https://ir.trevitherapeutics.c
Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer. Sep 26, 2024. Trevi Therapeutics Announces Additional ...
Trevi Therapeutics
https://www.trevitherapeutics.
We are dedicated to the development of Haduvio (oral nalbuphine ER) to help patients with chronic cough conditions.
Trevi Therapeutics, Inc. (TRVI) Stock Price
https://finance.yahoo.com
Find the latest Trevi Therapeutics, Inc. (TRVI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Trevi Therapeutics Reports Second Quarter 2024 Financial ...
https://www.prnewswire.com
Ended the second quarter of 2024 with $69.5 million in cash, cash equivalents and marketable securities with expected cash runway into 2026.
Trevi Therapeutics
https://finance.yahoo.com
Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.
TRVI: Trevi Therapeutics Inc
https://www.cnbc.com
Get Trevi Therapeutics Inc (TRVI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Trevi Therapeutics
https://lundbeckfonden.com
Related news about Trevi Therapeutics. Trevi Therapeutics Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvio™ in the Treatment of Prurigo Nodularis.
Trevi Therapeutics
https://www.annualreports.com
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio to treat serious ...
Trevi Therapeutics
https://www.stocktitan.net
Trevi is advancing various pruritic conditions through clinical development, including prurigo nodularis, which currently has no approved therapies in the US or ...